Tribute to Paul M. Vanhoutte, MD, PhD (1940–2019)
Arteriosclerosis, Thrombosis, and Vascular Biology
Professor Paul M. Vanhoutte passed away at the age of 78 years on August 23, 2019. All our thoughts are with his family, his wife, children, and grandchildren.
Professor Vanhoutte will be remembered as an internationally renowned figure in cardiovascular medicine and pharmacology for his major scientific contributions that unraveled the importance of endothelial cells regulating the underlying vascular smooth muscle in vascular health and disease and for his seminal discoveries that emphasized the complexity of that regulation. His scientific productivity included >669 original research articles, and 574 editorials, reviews, or book chapters in the cardiovascular field.
Paul M. Vanhoutte was born in Belgium; he obtained his medical degree at the University of Ghent and his PhD degree at the University of Antwerp. His outstanding academic career took him to prestigious Professor positions at the Mayo Clinic in Rochester, Minnesota, and at Baylor College of Medicine in Houston, TX. During this time, he also was involved at the highest levels in the International Union of Basic and Clinical Pharmacology. Later on, he moved to the pharmaceutical industry as Vice-President of R&D at the Institut de Recherches Internationales Servier, in France. From 2003 and until this summer, he held several academic positions at the University of Hong Kong, including Chair Professor and Head of the Department of Pharmacology and Pharmacy. He also was Visiting Professor at 13 different universities across the world and an active member of numerous scientific academies and societies. He never retired.
As many young research fellows, we were all attracted by his charismatic leadership, his profound passion, love of science, and his rare human and mentoring qualities. Throughout his life, Professor Vanhoutte expressed a genuine interest in the well-being of his fellows and in their scientific careers. He would encourage us by citing Alexander the Great “There is nothing impossible to him who will try.” Professor Vanhoutte traveled extensively but was never more than a phone call or an email away, always available to discuss scientific results. We all remember his excitement when discovering new or unexpected results through his famous words “I feel a paper coming on, sharpen your pencils!” which would even further fuel our energy to gather the necessary data to complete the study.
Some of us were with him at the beginning of his career when his interest was on catecholamines and the regulation of venous tone, working with Dr John Shepherd at the Mayo Clinic.1 Others joined his lab in the 80s, at the time of Robert Furchgott’s discovery of the obligatory role of the endothelium as a regulator of smooth muscle function and remember Paul’s profound admiration for Furchgott’s scientific mind.2–6 Other fellows took part in his work on dysfunctional and regenerated endothelium that led to the discovery of the underlying molecular mechanisms.7–10 Others were with him during the search for endothelium-dependent contracting11–15 and hyperpolarizing factors16–18 and their role in health and disease.
Professor Vanhoutte took much pride in organizing a series of scientific meetings titled Mechanisms of Vasodilatation. It was at the Fourth Mechanisms of Vasodilatation conference, held in Rochester in the summer of 1986, where Robert Furchgott and Louis Ignarro independently announced the finding that EDRF (endothelium-derived relaxing factor) was nitric oxide. Shortly thereafter, Professor Vanhoutte gained in a few years an international reputation for his work on EDRF, nitric oxide, and other endothelium-derived vasoactive factors in health and disease. He was the first to discover endothelium-dependent contractions, in particular in arteries exposed to hypertension. He was an extraordinary speaker, captivating his scientific audience until the end of his life, having given an address at Mechanisms of Vasodilatation in Rotterdam in May 2019. He was unique in constantly citing our names when describing our results at conferences, but he remained very humble regarding his own input; he even used to say that his only scientific contribution was to give his blood for experiments in the first article reporting endothelium-dependent responses to platelets. Professor Vanhoutte’s scientific life centered on blood vessels, veins, and arteries; “the tissue never lies,” he used to say when data were not what his fellow would expect from their experiment.
Aside from the lab, Paul Vanhoutte lived well, enjoying good food, good wine, good laughs, and sometimes a cigar. He loved jokes and always had a new one to tell the audience. Throughout the years, and particularly at venues such as Experimental Biology, Mechanisms of Vasodilatation, and EDHF Meetings, his current and former fellows would meet with him for “PMV dinner parties” that were not to be missed. We are honored to have accompanied him on his scientific journey.
Paul Vanhoutte will always be in our hearts.

References
1.
Shepherd, JT, Vanhoutte, PM: Veins and Their Control. Philadelphia, WB: Saunders Company; 1975.
2.
De Mey JG, Vanhoutte PM. Heterogeneous behavior of the canine arterial and venous wall. Importance of the endothelium. Circ Res. 1982;51:439–447. doi: 10.1161/01.res.51.4.439
3.
Vanhoutte PM. The endothelium–modulator of vascular smooth-muscle tone. N Engl J Med. 1988;319:512–513. doi: 10.1056/NEJM198808253190809
4.
Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J. 1989;3:2007–2018.
5.
Vanhoutte PM. How we learned to say NO. Arterioscler Thromb Vasc Biol. 2009;29:1156–1160. doi: 10.1161/ATVBAHA.109.190215
6.
Vanhoutte PM, Zhao Y, Xu A, Leung SW. Thirty years of saying NO: sources, fate, actions, and misfortunes of the endothelium-derived vasodilator mediator. Circ Res. 2016;119:375–396. doi: 10.1161/CIRCRESAHA.116.306531
7.
Cohen RA, Shepherd JT, Vanhoutte PM. Inhibitory role of the endothelium in the response of isolated coronary arteries to platelets. Science. 1983;221:273–274. doi: 10.1126/science.6574604
8.
Shimokawa H, Aarhus LL, Vanhoutte PM. Porcine coronary arteries with regenerated endothelium have a reduced endothelium-dependent responsiveness to aggregating platelets and serotonin. Circ Res. 1987;61:256–270. doi: 10.1161/01.res.61.2.256
9.
Vanhoutte PM. Endothelial dysfunction and atherosclerosis. Eur Heart J. 1997;18 (suppl E):E19–E29. doi: 10.1016/s0195-668x(97)90005-1
10.
Vanhoutte PM, Shimokawa H, Feletou M, Tang EH. Endothelial dysfunction and vascular disease - a 30th anniversary update. Acta Physiol (Oxf). 2017;219:22–96. doi: 10.1111/apha.12646
11.
Rubanyi GM, Vanhoutte PM. Hypoxia releases a vasoconstrictor substance from the canine vascular endothelium. J Physiol. 1985;364:45–56. doi: 10.1113/jphysiol.1985.sp015728
12.
Vanhoutte PM, Leung SWS. Hypoxic augmentation: the tale of a strange contraction. Basic Clin Pharmacol Toxicol. 2019. doi: 10.1111/bcpt.13295. [Epub ahead of print]
13.
Vanhoutte PM, Katusic ZS. Endothelium-derived contracting factor: endothelin and/or superoxide anion? Trends Pharmacol Sci. 1988;9:229–230. doi: 10.1016/0165-6147(88)90146-0
14.
Luscher TF, Vanhoutte PM. Endothelium-dependent responses in human blood vessels. Trends Pharmacol Sci. 1988;9:181–184. doi: 10.1016/0165-6147(88)90035-1
15.
Vanhoutte PM, Tang EH. Endothelium-dependent contractions: when a good guy turns bad! J Physiol. 2008;586:5295–5304. doi: 10.1113/jphysiol.2008.161430
16.
Feletou M, Vanhoutte PM. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br J Pharmacol. 1988;93:515–524. doi: 10.1111/j.1476-5381.1988.tb10306.x
17.
Vanhoutte PM. Endothelium-dependent hyperpolarizations: the history. Pharmacol Res. 2004;49:503–508. doi: 10.1016/j.phrs.2003.11.015
18.
Félétou M, Vanhoutte PM. Endothelium-derived hyperpolarizing factor: where are we now? Arterioscler Thromb Vasc Biol. 2006;26:1215–1225. doi: 10.1161/01.ATV.0000217611.81085.c5
19.
Bond RA. Vanhoutte at 60. Trends in Pharmacol Sci. 2001;22:P102. doi: 10.1016/S0165-6147(00)01649-7
Information & Authors
Information
Published In
Copyright
© 2019 American Heart Association, Inc.
History
Published online: 26 November 2019
Published in print: December 2019
Authors
Disclosures
None.
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
Purchase this article to access the full text.
eLetters(0)
eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.
Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.